Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Regul Homeost Agents ; 30(2): 559-63, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27358148

RESUMO

This study aimed to explore the correlation between Interleukin-6 (IL-6) and invasiveness of ectoderm cells of embryo in early pregnancy, in order to further discuss whether IL-6 can enhance invasiveness of ectoderm cells. The study lays the foundation for determination of pathogenesis of some gestation period-related diseases. Differences in mRNA and protein expression of trophoblastic cell line JEG-3 cells in IL-6, matrix metalloproteinase-2 (MMP-2) and MMP-9 were analyzed; the regulating effect of different concentrations of IL-6 on invasive ability of trophoblast cells was studied by Transwell assay; the effect of IL-6 on proliferation of ectodermal cell line JEG-3 of embryo was analyzed by methyl thiazolyl tetrazolium (MTT) assay. The invasive number of JEG-3 cells incubated by IL-6 (10 ng/ml) was higher than that of the control group, and the difference had statistical significance (p < 0.05). Results of using MMT assay to detect the effect of IL-6 on proliferation of trophoblastic cell line JEG-3 showed that JEG-3 cells before and after processing had no significant difference from the control group (p >0.05). Therefore, IL-6 can enhance invasiveness of ectoderm cells of embryo through activation of MMP-2.


Assuntos
Ectoderma/efeitos dos fármacos , Interleucina-6/farmacologia , Proliferação de Células/efeitos dos fármacos , Ectoderma/enzimologia , Feminino , Humanos , Metaloproteinase 2 da Matriz/genética , Metaloproteinase 9 da Matriz/genética , Gravidez
2.
J Biol Regul Homeost Agents ; 30(1): 103-10, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27049080

RESUMO

This study was carried out to investigate the expression changes of RanBP9 in tissue specimens and osteosarcoma cell strains and preliminarily explore its mechanism in osteosarcoma, so as to provide a theoretical foundation for follow-up experiments. The expression of RanBP9 in human osteosarcoma tissue specimens was detected by immunohistochemistry and the expression of RanBP9 messenger ribose nucleic acid (mRNA) in osteosarcoma cell strains was detected in real-time with polymerase chain reaction (PCR), and finally the expression of RanBP9 protein in osteosarcoma cell strains was detected by immunofluorescent staining and Western blot. Results demonstrated that RanBP9 was widely expressed in tissues, but also highly expressed in cells; moreover, the expression of RanBP9 was mainly concentrated in cytoplasm and nucleus, and partial expression was found in cell membrane. Thus, it can be concluded that RanBP9 is positively expressed in bone tumor tissues and cell strains.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/genética , Cartilagem/metabolismo , Proteínas do Citoesqueleto/genética , Proteínas Nucleares/genética , Osteossarcoma/genética , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Western Blotting , Cartilagem/patologia , Linhagem Celular Tumoral , Proteínas do Citoesqueleto/metabolismo , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Masculino , Proteínas Nucleares/metabolismo , Osteoclastos/metabolismo , Osteossarcoma/patologia , Inclusão em Parafina , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Adulto Jovem
3.
Changgeng Yi Xue Za Zhi ; 19(2): 181-6, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8828263

RESUMO

Pure rhabdomyosarcomas of the female genital tract mostly occur in infancy and childhood, in the form of sarcoma botryoides (a variant of embryonal rhabdomyosarcoma), with vagina and cervix as typically involved sites. Such tumors rarely occur in the uterine corpus and cervix of adults. We would like to report a pure embryonal rhab-domyosarcoma of the uterine corpus that arose in a 31-year-old, gravida 1, para 1, female patient with widespread bony metastasis, and which was originally mistaken for metastatic small cell carcinoma to bone marrow.


Assuntos
Carcinoma de Células Pequenas/patologia , Corpo Lúteo , Rabdomiossarcoma/patologia , Neoplasias Uterinas/patologia , Adulto , Carcinoma de Células Pequenas/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Rabdomiossarcoma/diagnóstico , Neoplasias Uterinas/diagnóstico
4.
Biochem Soc Trans ; 32(Pt 6): 1078-80, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15506970

RESUMO

PGs (prostaglandins) are synthesized through the cyclo-oxygenase (COX-1 and -2) pathway in a variety of cells in response to various physiological stimuli. All cells require at least one pathway for apoptosis, and mitochondrial play a central role in regulation of apoptosis. In a previous study, incubation of A549 cells with NS-398 (a COX-2-specific inhibitor) induced apoptosis and inhibited cell proliferation, and the concentrations of different PGs between various cellular compartments were found to be changed. To determine whether PG receptors are involved in this regulation, Western-blot analyses were performed specific for PGE(2) (EP receptors) and PGF(2alpha) (FP receptor) receptors, which were expressed in A549 cells. Western-blot analysis revealed that mitochondria that were isolated from A549 cells expressed EP receptors (EP2, EP3 and EP4), whereas FP receptors were undetectable. EP receptors (EP1, EP3 and EP4) and FP receptors were detected from A549 cell membrane. These results suggest that the change of PG production in A549-cells-induced cancer cell apoptosis might be related to the different expressions of EP and FP receptors in cell and mitochondrial membrane.


Assuntos
Apoptose/fisiologia , Mitocôndrias/fisiologia , Receptores de Prostaglandina/fisiologia , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Inibidores de Ciclo-Oxigenase/farmacologia , Humanos , Neoplasias Pulmonares , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/ultraestrutura , Nitrobenzenos/farmacologia , Receptores de Prostaglandina/efeitos dos fármacos , Sulfonamidas/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa